Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,201,358,780
+$136,747,082 QoQ
Shares Held
1,001,608
-13.5% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#75
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $5,015,687,266 across 13 Drug Manufacturers - General names. LLY ranks #2 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,536,227 | $1,429,019,361 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,001,608 | $1,201,358,780 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,938,774 | $497,624,704 | |
| 4 | JNJ |
Johnson & Johnson
|
1,657,928 | $421,063,972 | |
| 5 | ABBV |
AbbVie Inc.
|
1,521,377 | $382,839,306 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,581,691 | $331,747,292 | |
| 7 | AMGN |
Amgen Inc
|
821,365 | $297,432,693 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,327,511 | $249,351,182 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,201,358,780 | 1,001,608 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,064,611,698 | 1,157,476 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,007,324,521 | 937,325 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $507,583,461 | 665,247 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $390,077,590 | 500,401 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $534,812,238 | 647,543 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $359,478,712 | 465,646 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $525,541,377 | 593,202 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $629,353,176 | 695,126 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $542,931,280 | 697,891 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $434,782,538 | 745,870 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $471,199,976 | 877,255 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $319,505,754 | 681,278 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $212,498,335 | 618,771 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $273,894,894 | 748,674 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $206,644,253 | 639,073 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $251,173,845 | 774,678 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $218,902,086 | 764,403 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $215,474,802 | 780,084 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $163,294,817 | 706,751 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $144,309,091 | 628,743 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $129,097,662 | 691,027 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $113,505,558 | 672,267 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $87,981,310 | 594,388 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $56,056,468 | 341,433 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $38,938,564 | 280,699 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||